MICRON TECHNOLOGY INC Segments Disclosure
For the year ended 2025 | CMBU | CDBU | MCBU | AEBU | All Other | Unallocated | Total | ||||||||||||||||
| Revenue | $ | 13,524 | $ | 7,229 | $ | 11,859 | $ | 4,753 | $ | 13 | $ | — | $ | 37,378 | |||||||||
| Cost of goods sold | 5,867 | 3,995 | 8,650 | 3,566 | 14 | 413 | 22,505 | ||||||||||||||||
| Gross margin | 7,657 | 3,234 | 3,209 | 1,187 | (1) | (413) | 14,873 | ||||||||||||||||
| Research and development | 1,315 | 864 | 836 | 435 | — | 348 | 3,798 | ||||||||||||||||
| Selling, general, and administrative | 213 | 188 | 390 | 195 | — | 219 | 1,205 | ||||||||||||||||
Restructure and asset impairment | — | — | — | — | — | 39 | 39 | ||||||||||||||||
| Other operating (income) expense, net | — | 2 | 2 | — | — | 57 | 61 | ||||||||||||||||
| Operating income (loss) | $ | 6,129 | $ | 2,180 | $ | 1,981 | $ | 557 | $ | (1) | $ | (1,076) | $ | 9,770 | |||||||||
For the year ended 2024 | CMBU | CDBU | MCBU | AEBU | All Other | Unallocated | Total | ||||||||||||||||
| Revenue | $ | 3,792 | $ | 4,984 | $ | 11,667 | $ | 4,631 | $ | 37 | $ | — | $ | 25,111 | |||||||||
| Cost of goods sold | 2,677 | 3,638 | 10,222 | 3,598 | 20 | (657) | 19,498 | ||||||||||||||||
| Gross margin | 1,115 | 1,346 | 1,445 | 1,033 | 17 | 657 | 5,613 | ||||||||||||||||
| Research and development | 769 | 960 | 994 | 425 | — | 282 | 3,430 | ||||||||||||||||
| Selling, general, and administrative | 107 | 139 | 485 | 186 | (1) | 213 | 1,129 | ||||||||||||||||
Restructure and asset impairment | — | — | — | — | — | 1 | 1 | ||||||||||||||||
| Other operating (income) expense, net | (5) | (8) | (33) | (10) | — | (195) | (251) | ||||||||||||||||
| Operating income (loss) | $ | 244 | $ | 255 | $ | (1) | $ | 432 | $ | 18 | $ | 356 | $ | 1,304 | |||||||||
For the year ended 2023 | CMBU | CDBU | MCBU | AEBU | All Other | Unallocated | Total | ||||||||||||||||
| Revenue | $ | 1,872 | $ | 2,124 | $ | 7,394 | $ | 4,139 | $ | 11 | $ | — | $ | 15,540 | |||||||||
| Cost of goods sold | 1,801 | 1,967 | 9,072 | 2,905 | 4 | 1,207 | 16,956 | ||||||||||||||||
| Gross margin | 71 | 157 | (1,678) | 1,234 | 7 | (1,207) | (1,416) | ||||||||||||||||
| Research and development | 755 | 622 | 1,122 | 389 | — | 226 | 3,114 | ||||||||||||||||
| Selling, general, and administrative | 90 | 104 | 414 | 176 | (1) | 137 | 920 | ||||||||||||||||
Restructure and asset impairment | — | — | — | — | — | 171 | 171 | ||||||||||||||||
| Other operating (income) expense, net | (6) | (6) | (25) | (11) | — | 172 | 124 | ||||||||||||||||
| Operating income (loss) | $ | (768) | $ | (563) | $ | (3,189) | $ | 680 | $ | 8 | $ | (1,913) | $ | (5,745) | |||||||||
For the year ended | 2025 | 2024 | 2023 | ||||||||
| Unallocated | |||||||||||
Cost of goods sold: | |||||||||||
| Stock-based compensation | $ | 409 | $ | 312 | $ | 201 | |||||
Provision to write down inventories to net realizable value | — | — | 1,831 | ||||||||
Lower costs from sale of inventory written down in prior periods | — | (987) | (844) | ||||||||
Other | 4 | 18 | 19 | ||||||||
| 413 | (657) | 1,207 | |||||||||
Research and development: | |||||||||||
| Stock-based compensation | 347 | 296 | 226 | ||||||||
Other | 1 | (14) | — | ||||||||
| 348 | 282 | 226 | |||||||||
Selling, general, and administrative: | |||||||||||
| Stock-based compensation | 219 | 213 | 137 | ||||||||
| Restructure and asset impairment: | 39 | 1 | 171 | ||||||||
Other operating (income) expense, net: | |||||||||||
| Patent license charges | 57 | — | — | ||||||||
| — | — | 101 | |||||||||
| Litigation settlement | — | — | 68 | ||||||||
Patent cross-license agreement gain | — | (200) | — | ||||||||
| Other | — | 5 | 3 | ||||||||
| 57 | (195) | 172 | |||||||||
Total unallocated amounts | $ | 1,076 | $ | (356) | $ | 1,913 | |||||
For the year ended | 2025 | 2024 | 2023 | ||||||||
| CMBU | $ | 2,260 | $ | 1,112 | $ | 909 | |||||
| CDBU | 1,530 | 1,434 | 1,020 | ||||||||
| MCBU | 3,177 | 3,762 | 4,319 | ||||||||
| AEBU | 1,375 | 1,447 | 1,486 | ||||||||
| All Other | 5 | 7 | 3 | ||||||||
| Unallocated | 5 | 18 | 19 | ||||||||
| $ | 8,352 | $ | 7,780 | $ | 7,756 | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Oct 3, 2025 | Showing above |
| 2024 | Oct 4, 2024 | |
| 2023 | Oct 6, 2023 | |
| 2022 | Oct 7, 2022 | |
| 2021 | Oct 8, 2021 | |
| 2020 | Oct 19, 2020 | |
| 2019 | Oct 17, 2019 | |
| 2018 | Oct 15, 2018 | |
| 2017 | Oct 26, 2017 | |
| 2016 | Oct 28, 2016 | |
| 2015 | Oct 27, 2015 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.